Webinar Series — Support for Hospital Opioid Use Treatment (Project SHOUT)

Upcoming Event
Wednesday, March 21, 2018
12 - 1 PM
Register

About This Event

Patients with opioid use disorder are frequently hospitalized with complications from the condition, yet don’t receive treatment for their underlying disease. This is a missed opportunity that leaves patients at high risk of future overdose. These hospitalizations are an ideal opportunity to start effective medication treatment for addiction and connect patients to ongoing outpatient services.

Two key treatments for opioid use disorder — buprenorphine and methadone — have been proven to cut overdose rates by two-thirds, lower HIV infections, and reduce criminal behavior. As many as 70% of patients are still in treatment after one year, compared to 6% of patients receiving medication-free treatment. However, when patients being treated with buprenorphine or methadone are hospitalized, these medications are often discontinued, increasing their risk of relapse.

This program — Support for Hospital Opioid Use Treatment (Project SHOUT) — provides clinical leaders with the tools they need to start and maintain patients on buprenorphine or methadone during hospitalizations for any condition, be it medical, surgical, or obstetric. Specialists from the University of California, San Francisco (UCSF) will provide a suite of supports: coaching, toolkits, protocols, monographs for pharmacy and therapeutics committees, webinars, and onsite presentations.

Additional resources are available in a public Google Drive.

Hannah Snyder, MD
SHOUT Project Lead
Clinical Fellow, Primary Care Addiction Medicine
Division of HIV, ID, and Global Medicine & Dept. of Family and Community Medicine
UCSF at Zuckerberg San Francisco General

Diana Coffa, MD
SHOUT Project Mentor
Associate Professor
Director, Family and Community Medicine Residency Program
UCSF at Zuckerberg San Francisco General

Sarah Windels
SHOUT Project Manager
Independent Consultant

For more information or to join the coalition, please register here.

READ ABOUT PAST WEBINARS

 

 

Upcoming Webinars

SHOUT Webinar 7: Pharmacy Leadership in Hospital-Based OAT
Wednesday March 21, 2018, 12-1 PM (PT)

REGISTER NOW
(You will be asked to download our webinar app, Zoom.)

This webinar completes the discussion of Opioid Agonist Therapy (OAT) implementation in an inpatient setting begun in Webinars 5 and 6. This webinar will focus on the role of pharmacists in establishing a safe protocol for maintenance OAT in hospitalized patients. We will discuss the role of pharmacy leadership in development of hospital guidelines. Participants are encouraged to bring questions in these areas to raise with the panel.

Panel:

  • Moderator: Hannah Snyder, MD, clinical fellow, primary care addiction medicine at UCSF at Zuckerberg San Francisco General Hospital (SFGH)
  • Curt Geier, PharmD, BCCCP, clinical pharmacist, emergency medicine assistant clinical professor, UCSF, SFGH
  • Michelle Geier, PharmD, psychiatric clinical pharmacist supervisor, San Francisco Department of Public Health
  • Kristin Harter, PharmD, women’s health clinical pharmacist, assistant clinical professor, UCSF School of Pharmacy, SFGH

 

 

Past Webinars

SHOUT Webinar 1: The Case for Inpatient Opioid Agonist Therapy (OAT)
Held: Wednesday, November 15, 2017

Opioid addiction and opioid-related death rates are climbing, and our medical system is on the front lines. Effective medications can save lives, but not enough patients have access to them. While thousands of patients with opioid use disorder are hospitalized in California each year, they are rarely started on lifesaving treatment for their addiction. In this webinar, we examined the efficacy of medications for opioid use disorder, evidence for prescribing these medications in hospital settings, and strategies for implementing prescription programs in your hospital.

Presenter:

  • Diana Coffa, MD, associate professor, UCSF primary care addiction medicine fellowship program

 

SHOUT Webinar 2: Buprenorphine and Methadone Induction
Held: Wednesday, November 29, 2017

Buprenorphine and methadone are safe, effective, and potentially lifesaving treatments for hospitalized patients. This practical webinar gave providers the clinical tools necessary to provide methadone and buprenorphine in inpatient settings for nonpregnant adults. Participants learned about both the clinical guidelines produced by SHOUT and common clinical scenarios that providers face during treatment with opioid agonist therapy.

Presenters:

  • Hannah Snyder, MD, UCSF clinical fellow of primary care addiction medicine
  • Michelle Geier, PharmD, psychiatric clinical pharmacist supervisor, San Francisco Department of Public Health

 

SHOUT Webinar 3: Acute Pain and Perioperative Management in Opioid Use Disorder
Held: Wednesday, December 13, 2017

Management of acute pain in patients with opioid use disorders can be challenging, and many clinical questions arise when patients are already on medication-assisted treatment. This webinar focussed on management of acute pain and control of pain and cravings in the perioperative period for patients who are taking methadone, buprenorphine, or naltrexone for opioid use disorder. Led by an inpatient provider and a hospitalist, the session will cover practical steps for achieving analgesia and preventing relapse.

 

SHOUT Webinar 4: Buprenorphine and Methadone in Pregnancy
Held: Wednesday, December 20, 2017

Pregnancy is a time when women with opioid use disorder may be highly motivated to decrease their opioid use. Both methadone and buprenorphine are safe and effective in pregnancy. This webinar addressed the unique opportunities and challenges of treating opioid use disorder in pregnancy. It will address initiation of methadone and buprenorphine, as well as management of pain for women on these medications during pregnancy.

 

SHOUT Webinar 5: Inpatient Hospital Logistics for Opioid Agonist Therapy
Held: Wednesday, January 17, 2018

This webinar supported hospitals in implementing opioid agonist therapy (OAT) in the inpatient setting. It reviewed steps to implementation, including increasing the number of providers with “X” waivers and communicating effectively with hospital administration. This was an interactive webinar inviting participant questions and comments. The panel also discussed regulations of methadone and buprenorphine as well as insurance coverage for these medications.

Panel:

  • Diana Coffa, MD, associate professor, UCSF primary care addiction medicine fellowship program
  • James Gasper, PharmD, BCPP, psychiatric and substance use disorder pharmacist at California Department of Health Care Services
  • Hannah Snyder, MD, clinical fellow, primary care addiction medicine at UCSF/Zuckerberg San Francisco General Hospital

 

 

SHOUT Webinar 6: Discharge Planning and ED Induction
Held: Wednesday, February 14, 2018

This webinar continued the discussion of Opioid Agonist Therapy (OAT) implementation in an inpatient setting begun in Webinar 5. We focussed on discharge planning for inpatients on buprenorphine. We also reviewed models for connection to outpatient care on discharge, especially in communities where buprenorphine prescribers are less available. Finally, we briefly discussed the option of buprenorphine inductions in the ED.

  • Moderator: Hannah Snyder, MD, clinical fellow, primary care addiction medicine at UCSF at Zuckerberg San Francisco General Hospital
  • Diana Coffa, MD, associate professor, UCSF primary care addiction medicine fellowship program, UCSF
  • Andrew Herring, MD, attending emergency physician at Highland Hospital-Alameda Health System, and clinical instructor at UCSF